Q&A — Psychiatrist and historian Joel Braslow
Psychotropic drugs have severely narrowed how we treat psychiatric disorders — to the detriment of patients and society as a whole. A look at the past suggests a better way forward.
The standard of care for the severely mentally ill in the United States has drastically changed since the 1950s, when more than half a million patients resided in enormous state hospitals. As pharmaceutical firms developed new antipsychotic medications, national policy shifted such that most of the old hospitals have now closed. Today, the majority of US patients, even those with serious mental illnesses such as schizophrenia, bipolar syndrome and major depression, receive only short-term, in-patient medical treatment to quell symptoms before being sent home.
The old asylums were the scenes of some well-publicized abuses and poor conditions. Yet their closures and the parallel embrace of medications did not solve the issue of how to best care for people. The current mental-health system leaves many mentally ill patients no better off, says Joel Braslow, a historian and psychiatrist at the University of California, Los Angeles. In some cases, the situation has grown worse.
In the 2019 Annual Review of Clinical Psychology, Braslow and UCLA colleague Stephen Marder argue that our current “age of psychopharmacology” has shrunk society’s sense of responsibility toward the mentally ill. Whereas most psychiatrists once viewed mental illness as a complex interaction between a patient’s biology and social context, Braslow and Marder contend, it is now often seen more narrowly as merely symptoms to be medicated.
Braslow blames this shift for what he calls our society’s “total failure” in caring for its most vulnerable members: Roughly 140,000 seriously mentally ill people are now homeless on city streets, while 350,000 others are serving time in prisons and jails, where their illnesses get little treatment.
Knowable Magazine spoke with Braslow about the history of this transformation and what it would take to better serve the multitudes of people living with psychiatric problems.
This conversation has been edited for length and clarity.
Why do you call this the “age of psychopharmacology”?
I think about it in two different but interrelated ways. First, it underlines our growing reliance on drugs to treat disorders of the mind. Today, one in six Americans takes a psychoactive drug. This has reinforced the idea that the drugs treat specific diseases, much like insulin treats diabetes. For example, Tipper Gore (the ex-wife of former Vice President Al Gore) has explained her own depression as a chemical imbalance, with her brain running out of serotonin like a car runs out of gas. This description implies that depression has both a specific cause — in her case, depleted serotonin — and a specific cure, a drug.
Secondly, there’s our shrinking vision of what causes psychiatric disease and what we can do clinically for those who suffer from it. Prior to the late 1960s and 1970s, American psychiatrists tended to take a more expansive view. Today’s greater focus on the individual and a simple model of disease has helped justify the belief that drugs or psychotherapies hold the key to alleviating psychiatric disease. However, this view ignores the fundamental nature of psychiatric disease as simultaneously biological, psychological and social.
What accounts for this shift?
Psychoactive drugs have been used since the 19th century, but they were generally regarded as little more than sedatives — referred to as “chemical straitjackets.” The chance discovery of the major classes of psychotropic drugs in the 1950s changed the status of psychopharmacology. These new compounds did more than simply sedate; they actually treated many of the symptoms of psychiatric disease, such as hallucinations, depressed mood and disordered thoughts.
However — and this is a crucial point — throughout the 1950s and much of the 1960s, psychiatrists largely saw psychotropic drugs as just one part of an overall regimen, a part that neither dominated nor defined the nature of the disease and its treatment. Psychiatrists continued to see psychiatric disease in a holistic manner, in which symptoms could involve an individual’s failure to function in the social world and their inner torment. Treatment remained similarly expansive, especially when the illness warranted state hospitalization.
Things changed dramatically from the 1970s onward. It’s tempting to attribute this to the drugs’ effectiveness, but this is simply not the case. There has been little change in the actual efficacy of antidepressants, antipsychotics and anti-anxiety drugs over the last half-century. Social, economic and cultural circumstances did far more to bring on the age of psychopharmacology than did the effectiveness of the drugs themselves.
For one thing, psychiatric hospital administrators came under increasing pressure to decrease their hospitalized patient population. Hospital records from the 1970s show doctors under pressure to discharge patients earlier and earlier. So physicians, understandably, focused on symptoms that could be quickly and easily treated, and relied increasingly on drugs as their primary intervention. Under such circumstances, it became more and more impossible to address the thornier problems of how the patients functioned in the world.
You write that this change was also influenced by politics?
Yes. For nearly 150 years, state governments believed that society and physicians had a moral responsibility to provide care for all those afflicted with mental illness. But beginning in the late 1960s and 1970s, the welfare state came under increasing attack with the belief that individuals needed to take individual responsibility for themselves. State governments were primarily responsible for the smooth running of market economies and not for individual welfare. The elections of Ronald Reagan in the US and Margaret Thatcher in the UK underlined this shift in political culture.
These changes shifted care priorities away from state hospitals and toward care in the community. But that has become increasingly fragmented, decentralized and subject to the logic of market forces rather than to the needs of those with serious mental illness.
The political ideology that emphasizes individual responsibility fits neatly with a belief that disease is largely a problem of biology and/or psychology and that the solution is a treatment that focuses on the individual’s psychology or biology.
Given that we’re relying more on medications, how well do they actually work?
That’s a difficult question to answer. Take schizophrenia, for example. We don’t have a good understanding of the causes of what are likely multiple different kinds of schizophrenia, but there’s a growing belief that antipsychotic drugs can do little for the fundamental symptoms of apathy, social withdrawal and cognitive deficits. These drugs do, however, treat other symptoms — hearing voices, speaking incoherently and behaving in an agitated way.
We have good evidence that antipsychotic drugs help prevent relapse in the short run, although the jury is still out whether someone should be on antipsychotic drugs for a lifetime. So, yes, they work, but only with a number of important caveats. I think the same could also be said for antidepressant drugs.
You write that the medical system’s increasing reliance on randomized controlled trials helped fuel the shift toward drugs. Is the problem that it’s somehow easier to test medications than psychotherapies?
The short answer to that is yes.
A randomized controlled trial requires easily measurable variables and, consequently, has shifted our understanding towards an increasingly reductionistic view of psychiatric disease that excludes many of the social and psychological realities. It encourages us to think in terms of specific interventions, such as psychotropic drugs, that treat a specific, discrete disease, just like antibiotics treat bacterial infections. This way of thinking fails to accommodate the complex social and psychological deficits intrinsic to psychiatric disease.
How have the patients fared with these changes?
Despite good intentions, advances in neuroscience and an increasingly large number of psychotropic drugs, those afflicted with serious mental illness have not done well. Overall, outcomes such as mortality and social function have worsened for the vast majority with serious mental illness. You can see it in the unprecedented population of mentally ill homeless people — 60,000 just in Los Angeles. We’re allowing people who are disabled by psychosis to languish in the streets. This wouldn’t happen with cardiac patients.
And a lot of those homeless people end up in jail.
True. Today there are about 5,000 seriously mentally ill people in the Los Angeles County jail. I have a hard time going to the jail myself — it’s such a horrible place. Many of the sickest patients refuse medications, often exacerbating their psychotic symptoms. The sheriff has little recourse but to house the most psychotic, non-compliant inmates in isolation, so as to be the least disruptive to the other inmates and guards.
About a thousand inmates are in solitary confinement, in individual Plexiglas cells for 23 hours a day. At the same time, these terribly psychotic individuals are left to disrobe, smear feces and a variety of other psychotic symptoms that worsen under conditions of isolation and deprivation. Any time they’re out of their cells, they are almost invariably shackled, even while seeing a psychiatrist. It’s heartbreakingly sad.
So how should society respond? Do we need to go back to the asylums of the past?
I think we need to learn from the positive aspects of asylum care. Rather than either reestablishing the asylums or intensifying the alienation and neglect of the last 50 years, we need to come up with new, evidence-based ways of caring for those with serious mental illness.
Once we acknowledge the reality of mental illness as a disease that robs its victims of meaning, social connections and the ability to function in contemporary society, we can start designing interventions that address this reality. We cannot simply wish away the complexity of psychiatric disease and the kinds of interventions that are necessary for humane, scientifically based care.
12 ways a therapist can benefit from a Notion template: 1. Improved organization: A Notion template can help a therapist stay organized and keep track of client information, session notes, and treatment plans in one place. 2. Streamlined workflow: A template can help...
The Cognitive-Theoretic Model of the Universe (CTMU) is a philosophical theory of the relationship between mind and reality. It is the first "self-simulation" theory of reality, described as a reflexive, tautological, and profoundly self-contained intrinsic language...
Enneagram Type 9, the “Peacemaker” or “Mediator.” Type 9s are known for their empathy, diplomacy, and desire for harmony. In the workplace, Type 9s tend to thrive in careers that allow them to utilize their interpersonal skills, creativity, and problem-solving abilities.
Here are some career paths that may be well-suited for Enneagram Type 9s:
1. Counselor or therapist:
Enneagram Type 8, the “Challenger” or “Protector.” Type 8s are recognized for their strong sense of confidence, assertiveness, and desire for control. In a professional setting, Type 8s tend to thrive in careers that allow them to utilize their leadership skills, strategic thinking, and problem-solving abilities.
The following career paths may be well-suited for Enneagram Type 8s:
1. Executive or manager:
The Enneagram is a system of personality that describes people in terms of nine personality types, each with its own core motivations, fears, and internal dynamics. It is a model of the human psyche understood as a typology of nine interconnected personality types....
Enneagram Type 7, the “Enthusiast” or “Adventurer.” Type 7s are known for their strong desire for new experiences, positive outlook, and tendency to avoid pain and discomfort. In the workplace, Type 7s tend to thrive in careers that allow them to use their creativity, interpersonal skills, and enthusiasm.
Enneagram Type 6s tend to be well-suited for careers that allow them to use their analytical skills, interpersonal skills, and practical problem-solving abilities. Here are some career paths that might be suitable for an Enneagram Type 6:
1. Project manager:
Enneagram Type 5, also known as the “Investigator” or “Observer,” is typically characterized by a desire for knowledge, competence, and independence.
When it comes to work and career, Enneagram Type 5s tend to be well-suited for careers that allow them to use their analytical and intellectual abilities, as well as those that offer a degree of autonomy and independence.
Enneagram Type 4s tend to be well-suited for careers that allow them to use their creativity, intuition, and interpersonal skills. Here are some career paths that might be suitable for an Enneagram Type 4:
1. Artist or designer
Enneagram Type 3s tend to be well-suited for careers that allow them to use their ambition, adaptability, and interpersonal skills. Here are some career paths that might be suitable for an Enneagram Type 3:
Enneagram Type 2s tend to be well-suited for careers that allow them to use their interpersonal skills, compassion, and desire to make a positive impact. Here are some career paths that might be suitable for an Enneagram Type 2:
1. Social worker: Type 2s may enjoy careers in social work, where they can use their empathy and interpersonal skills to support individuals and families in need.
Enneagram Type 1s tend to be well-suited for careers that allow them to use their attention to detail, strong work ethic, and desire to make a positive impact. Here are some career paths that might be suitable for an Enneagram Type 1
To survive the ‘Great Reset’ identify the skills that will be in high demand in the future and invest in developing them. This could include technical skills like coding or data analysis, as well as “soft” skills like communication and problem-solving.
Antoine-Augustin Parmentier is a well-known figure in the history of food and nutrition. He was a French pharmacist, nutritionist, and agronomist who lived during the 18th century. Parmentier is best known for his advocacy of the potato as a food source and his...
Mimetic desire, a concept introduced by the French philosopher René Girard, refers to the imitation of the desires of others. René Girard was a French philosopher and anthropologist who developed a theory of mimetic desire and the scapegoat mechanism. He was born in...
Are you and your partner looking to strengthen your relationship and take it to the next level? Couples therapy worksheets can be a valuable tool in achieving this goal. These worksheets are designed to help couples improve communication, resolve conflicts, and deepen...
The client presented in this case study illustrated successful PTSD treatment using a novel, brief intervention requiring fewer than 5 hours of treatment. Using diagnostic criteria for Military trauma (PCL-M ≥ 50) his intake score was 73 and no longer met criteria for PTSD diagnosis following RTM. These gains were maintained, as reported above, at one-year posttreatment.
This innovation was announced by OpenAI CEO Sam Altman. Although Sora is not yet available to the public, access is being granted to a select group of individuals, including red teamers who will assess potential risks associated with the model’s release, as well as a limited number of visual artists, designers, and filmmakers to provide feedback on how to advance the model for creative professionals. OpenAI is also working on building classifiers that can identify videos generated by Sora and plans to include C2PA metadata for provenance verification. The technical report released by OpenAI does not disclose the data that Sora was trained on.
Apple Vision Pro offers immersive, customizable environments that can make meditation more accessible and personalized. Its advanced features, such as eye-tracking and spatial audio, provide new ways to guide and enhance meditation, opening up new possibilities for mindfulness practices
While OpenAI Sora offers many benefits, there are also potential challenges to consider. These include concerns about data privacy, the ethical implications of AI-generated content, and the potential impact on employment in the video production industry. It will be important for businesses to address these challenges proactively and ethically as they adopt AI technology.
The No. 1 Nutrient for Brain Health as You Age, According to a Dietitian, is Omega-3 fatty acids, particularly EPA and DHA, which are critical for healthy aging and cognition. Several other nutrients are also important for brain health, such as flavonoids,...